The Cooper Companies Inc. (COO) Stock

The Cooper Companies Inc. trades at a P/E ratio of 33.17, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 15.41 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.08 indicates reasonable value when growth is considered.

With a beta of 0.97, The Cooper Companies Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.61 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

The Cooper Companies Inc. achieves a profit margin of 10.10%, meaning it retains $10.10 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 16.60% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 5.01% and ROA at 3.79%, the company achieves moderate returns on invested capital.

The Cooper Companies Inc.'s revenue grew by 5.70% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 5.80% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against MEDICAL INSTRUMENTS & SUPPLIES industry averages for proper context.

The Cooper Companies Inc. has a market capitalization of $13.5B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 198.81M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL INSTRUMENTS & SUPPLIES industry, it competes with other firms in this sector.

The Cooper Companies Inc.'s book value per share is $42.02, while the current stock price is $69.70, resulting in a price-to-book (P/B) ratio of 1.66. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

17 analysts cover COO with 65% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $84.47 implies 21.2% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:4 Strong Buy, 7 Buy, 6 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.